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Abstract.  The tissue distribution of the extracellular 
matrix glycoprotein, tenascin,  during cartilage and 
bone development in rodents has been investigated by 
immunohistochemistry.  Tenascin was present in con- 
densing mesenchyme of cartilage anlagen,  but not in 
the surrounding  mesenchyme. In fully differentiated 
cartilages,  tenascin was only present in the perichon- 
drium.  In bones that form by endochondral ossifica- 
tion, tenascin reappeared around the osteogenic cells 
invading the cartilage model.  Tenascin was also pres- 
ent in the condensing mesenchyme of developing 
bones that form by intramembranous  ossification and 
later was present around the spicules of forming bone. 
Tenascin was absent from mature bone matrix but per- 
sisted on periosteal and endosteal surfaces. 
Immunofluorescent staining of wing bud cultures 
from chick embryos showed large amounts of tenascin 
in the forming cartilage nodules.  Cultures grown on a 
substrate of tenascin produced more cartilage nodules 
than cultures grown on tissue culture plastic.  Tenascin 
in the culture medium inhibited the attachment of 
wing bud cells to fibronectin-coated substrates.  We 
propose that tenascin plays an important  role in chon- 
drogenesis by modulating fibronectin-cell interactions 
and causing cell rounding and condensation. 
T 
HE extracellular  matrix  (ECM) ~ is important  for car- 
tilage and bone differentiation and is the very basis of 
the function of the fully differentiated  hard tissues. 
Cartilage  differentiation  begins with the rounding  and con- 
densation of mesenchymal cells, followed by differentiation 
which is characterized  by the synthesis of cartilage-specific 
matrix components.  Bone development can occur either by 
intramembranous  or endochondral  ossification.  Intramem- 
branous  ossification  takes  place within  a  layer  of mesen- 
chyme, whereas endochondral  ossification  occurs within a 
cartilage  model in which the chondrocytes hypertrophy and 
are then replaced by invading osteogenic  cells. 
Several  immunohistochemical  studies  have been carried 
out which have demonstrated changes in ECM components 
during cartilage and bone differentiation.  These ECM mole- 
cules can arbitrarily be divided into two overlapping groups: 
those which appear early in differentiation and may therefore 
promote this  process, and those which are present in the 
differentiated  tissue  and  have  a  predominantly  structural 
role.  Collagen type I, fibronectin,  and a large chondroitin 
sulfate proteoglycan increase in density in the cartilage  an- 
lage of the embryonic chick limb bud at the time of mesen- 
chymal condensation  (11, 17). As cartilage  differentiation 
proceeds, collagen  type I and the large chondroitin  sulfate 
proteoglycan are replaced by the cartilage-specific  collagen 
type 1I and a cartilage-specific  proteoglycan which persist 
throughout differentiation  (11, 17, 31). Hyaluronic acid con- 
1. Abbreviation used in this paper:  ECM, extracellular matrix. 
centration  remains  constant  in chondrogenic  areas during 
condensation,  but increases in peripheral nonchondrogenic 
mesenchyme (31). Collagen type I reappears as the cartilage 
model is destroyed during  endochondral  ossification  (36). 
Collagen type X is present only in the hypertrophic  cartilage 
which  exists  as  an  intermediate  stage  in  endochondral 
ossification  (29). 
In vitro and in vivo studies have confirmed the importance 
of many  of these  ECM  molecules  in  cartilage  or  bone 
differentiation.  Chondrogenesis  in vitro is stimulated by type 
I and type II collagen (18), chondroitin  sulfate proteoglycan 
(20),  hyaluronic  acid (22),  and by notochord  ECM  (19). 
Chondrogenesis  in vitro is inhibited by fibronectin  (27, 34, 
38). Chondrogenesis  and osteogenesis in vivo are stimulated 
by demineralized  bone matrix (28). 
Fully differentiated  cartilage  and bone each contain  their 
own tissue-specific ECM components as well as ECM mole- 
cules found in other tissues. The particular combinations  of 
ECM molecules are responsible for the special  structural 
properties of the two tissues. The major components of carti- 
lage matrix,  hyaluronic acid-bound proteoglycans,  and type 
II collagen,  confer on cartilage  its characteristic  resilience. 
Bone matrix consists mainly of collagen type I and crystals 
of hydroxyapatite,  the combination of which makes  bone 
rigid.  Cartilage  and bone also contain minor tissue-specific 
collagen types, other proteins, and proteoglycans  (discussed 
in references  5, 24, 26, and 35). 
The ECM glycoprotein tenascin,  which was originally de- 
scribed as myotendinous antigen and is probably identical to 
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protein (GMEM) (4), and J1 (21), has a strikingly restricted 
tissue distribution during embryogenesis (7,  10). The peri- 
chondrium of vertebral and limb cartilage of chick fetuses 
before ossification is one of the tenascin-containing  tissues 
(7).  In a  recent report it has been suggested that tenascin 
could be a  structural  component of differentiated cartilage 
(35). The present study was undertaken to obtain clues to the 
role of tenascin in cartilage and bone development and to de- 
termine whether it is present in the two differentiated tissues. 
The time of expression of tenascin  during  chondrogenesis 
and osteogenesis in the rat and mouse has been investigated 
by immunohistochemistry.  The effect of exogenous tenascin 
on limb bud cultures  undergoing  chondrogenesis  has also 
been investigated. 
Materials and Methods 
Protein Purification and Antisera 
Tenascin was purified from the conditioned medium of primary chick em- 
bryo fibroblast cultures by affinity chromatography using a monoclonal anti- 
body, as previously described (8). Fibronectin was purified from newborn 
calf serum using gelatin-agarose affinity chromatography as described (9). 
Rabbit antisera to tenascin and fibronectin  were obtained previously (10, 13). 
Guinea  pigs were  immunized against tenascin purified from fibroblast- 
conditioned medium as described above.  The guinea pig immunization 
schedules and processing of antisera were as previously described for rab- 
bits (10). 
Frozen Sections and Immunofluorescence 
Fetuses  were  obtained  from outbred  Sprague-Dawley  rats  and  female 
BALB/c mice crossed with male CDI mice. Bronchi were dissected from 
adult Sprague-Dawley rats. Whole fetuses of various ages (vaginal plug = 
day 0) and bronchi were embedded in Tissue-Tek O.C.T. compound (Miles 
Laboratories, Inc., Naperviile, IL), frozen in ethanol/dry ice, and stored at 
-70"C. Sections (10-20-1tm thick) were cut at -20"C and placed on gela- 
tin-coated slides. Frozen sections through whole heads of 20--d-old rats 
were a kind gift from Dr. Tuomo Kantomaa (University of Oulu,  Oulu, 
Japan). The 204tm sections were taken on a plastic tape and fixed in 96% 
methanol. All sections were stored in tight boxes at  -20~  until used. 
Some sections were treated with bovine testicular hyalumnidase (Calbio- 
chem, Lucerne, Switzerland; 0.1  rag/m1 in PBS, 30 win, 220C)  or col- 
lagenase (type I; Sigma Chemical Co., St. Louis, MO; 0.5 mg/ml in PBS, 
20 win, 370C) and then washed in PBS before immunofluorescent staining. 
Sections were stained with anti-tenascin, anti-fibronectin, or preimmune 
serum by indirect immunofluorescence as previously described (10). For 
immunothorescent staining anti-fibronectin was diluted 1:I00  and anti- 
tenascin and preimmune sera were diluted 1:100 for rat tissues and 1:50 for 
mouse tissues. For immunoperoxidase staining the Vectastain ABC kit was 
used (Vector Laboratories, Inc., Burlingame, CA). The sections were in- 
cubated for 1 h at 37"C with anti-tenascin (diluted 1:200) or normal rabbit 
serum. After staining, the sections were mounted with Aquamount (Gurr, 
BDH Chemicals Ltd., Poole, UK). Some sections were stained with Alcian 
blue to stain glycosaminoglycans, and counterstained with hematoxylin and 
picro-ponceau and other sections were stained with hematoxylin and eosin 
by standard histological methods. 
Wing Bud Cultures 
Wing bud cultures were prepared from 4-d-old chick embryos according 
to the method of Ahrens et al. (1) with minor modifications. Dissected wing 
buds were incubated for  10 win in a  shaking waterbath in 0.1%  trypsin 
(Gibco, Basel, Switzerland), 0.1% collagenase 0Vorthington Biochemical 
Corp., Freehold, NJ),  10% FCS (Gibeo) in calcium- and magnesium-free 
PBS.  The  resulting  cell  suspension  was  mechanically  dissociated  in 
DME/10% FCS until no clumps were visible. The cell suspension was ad- 
justed to 2  ￿  106 ceUs/ml. The cells were plated on 96-well cluster plates 
(Falcon Labware, Cockeysville, MD) in 100-ttl aliquots in DME/10% FCS. 
Twofold serial dilutions of the cells were prepared and each experiment was 
carried out at four cell densities, allowing us to select the optimal cell den- 
sity for analysis. Cultures seeded too densely showed no difference in carti- 
lage nodule formation between the different treaUnents and cultures seeded 
too sparsely contained insufficient cartilage nodules for analysis. The best 
results were usually obtained at a cell density of 106 or 0.5  ￿  106 cells/ml. 
The wells were either used uncoated or after coating with a  solution of 
fibmnectin or tenascin at 50 ~tg/ml in PBS for 15 win at room temperature. 
The wells were washed with medium before the cells were plated. In one 
experiment wells were coated with tenascin, fibmnectin, or a solution of 
BSA (1% in PBS), then treated with bovine testicular hyaluronidase (Calbio- 
chem; 0.1 mg/ml in PBS containing 1% BSA, 30 rain, 22~  or I%'BSA 
in PBS and then washed with medium before the cells were plated. 3 or 4 d 
after plating, the cultures were fixed with 4%  formaldehyde in PBS and 
stained with Alcian blue at pH 1 (1% in 0.1 M HCI; reference 23). The AI- 
cian blue-stained nodules were counted and the results were analyzed using 
the t test. 
Attachment Assay 
The dissociated wing bud cells were plated on the different substrates (de- 
scribed above) at 2.5  ￿  105 cells/ml in DME/10% FCS using 50 ttl/well. 
50 gl of PBS or tenascin (50 gtg/ml) in PBS were added immediately to the 
wells. After 16 h the cells were washed, fixed with 4% formaldehyde in PBS, 
stained with hematoxylin, and counted.  Since the cells attached best to 
fibronectin, cell attachment on fibmnectin was arbitrarily designated as 
100% attachment. 
Immunofluorescence of Cell Cultures 
The cells were cultured on 8-chamber plastic slides (LabTek; Miles Labora- 
tories, Inc.). Before staining they were washed with PBS, fixed with 4% 
formaldehyde in PBS for 20 win, treated with 0.2% Triton X-100 in PBS 
for 5 win, and washed three times for 5 rain with PBS/0.1% BSA. They were 
stained with the antisera as described for the cryosections. The cultures that 
were double-stained for tenascin and fibmnectin were treated first with rab- 
bit anti~fibronectin, washed, then treated with guinea pig anti-tenascin. 
FITC  goat anti-rabbit IgG (Miles-Yeda  Ltd.,  Rehovot,  Israel) and rho- 
damine-conjugated goat anti-guinea pig IgG (Cappel Laboratories, Mal- 
vern, PA; CooperBiomedical, Inc., Malvern, PA), each diluted 1:50 then 
mixed in  equal  volumes,  were  used  to  detect the  anti-fibronectin and 
anti-tenascin antibodies, respectively. 
Results 
Cartilage Development 
Tenascin was detectable in the condensing mesenchyme of 
cartilage anlagen.  Fig.  1, a-d,  shows longitudinal  sections 
through the trachea of a  17-d-old rat fetus. The condensing 
mesenchyme of the presumptive tracheal cartilage rings con- 
tained tenascin  in a  fibrillar distribution  whereas the sur- 
rounding  loose  mesenchyme  was  negative  for  tenascin. 
Fibronectin,  although present in a higher concentration  in 
the cartilage anlagen,  was additionally  present throughout 
the surrounding mesenchyme. Tenascin was also selectively 
localized in the condensing mesenchyme of future interver- 
tebral discs (Fig.  3 b). 
As condensed cartilage mesenchyme begins to differenti- 
ate,  cartilage-specific  matrix  is laid down and pushes the 
cells apart.  In all the cartilages studied, including tracheal, 
sternal, and intervertebral disc cartilages, tenascin was pro- 
gressively lost from the matrix with increasing chondrocyte 
differentiation. In the mature hyaline cartilage matrix of the 
adult rat bronchial rings no tenascin was detectable (Fig.  1, 
e-h). There was faint specific staining with anti-tenascin in 
the perichondrium. The differentiated fibrocartilage of inter- 
vertebral  discs  of  17-d-old  rat  fetuses  also  contained  no 
tenascin; tenascin was, however, detectable in the matrix sur- 
rounding the condensing cells at the periphery of the discs 
(Fig. 3 g). In contrast, fibronectin was present in the differ- 
entiated  hyaline  cartilage  of the  bronchus  (Fig.  1 d)  and 
fibrocartilage of the intervertebral  discs (Fig.  3 h). 
The Journal  of Cell Biology,  Volume 105, 1987  2570 Figure 1.  Distribution of tenascin and fibronectin in fetal and adult rat cartilage. Serial longitudinal cryosections through  17-d-old fetal 
rat trachea (a-d)  and adult rat bronchus (e-h) stained with Alcian blue and counterstained with hematoxylin and picro-poncean (a and 
e), or by indirect immunofluorescence with preimmune (b and  f), anti-tenascin (c and g ), or anti-fibronectin  (d  and h) serum, cm, Condens- 
ing mesenchyme of presumptive cartilage rings; dc, differentiated cartilage; lu, lumen. The arrows in g  indicate faint tenascin staining 
in the perichondrium. All other fluorescence in g  is nonspecific as demonstrated in f  Bar, 50 ltm. 
Mackir et al. Tenascin in Chondrogenesis and Osteogenesis  2571 Figure 2. Distribution  of  tenascin and fibronectin in fetal membrane bones. Serial sagittal cryosections through the frontal bone of LS-d-old 
(a and c) and 17-d-old (b and d) rat fetuses,  stained with Alcian blue counterstained  with hematoxylin and picro-ponceau (a and b), or 
by indirect  immunofluorescence with anti-tenascin (c and d).  Higher magnification  of serial  sections  of 15-d-old fetal rat frontal  bone 
(e and f) and the membranous part of the mandible (g and h), stained with anti-fibronectin, (e and g) or anti-tenascin (fand h). br, brain; 
bs, bone spicules; jb, condensing mesenchyme of frontal  bone. Bar,  50 gm. 
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tilage sections with hyaluronidase unmasks fibronectin stain- 
ing  (37) and that tenascin staining in developing teeth is 
enhanced  by  hyahronidase  or  collagenase  pretreatment 
(Thesleff, I., E. Mackie, S. Vainio, and R. Chiquet-Ehris- 
mann, manuscript submitted for publication). Thus, sections 
containing differentiated  cartilage were treated with these en- 
zymes before processing for indirect immunofluorescence. 
Neither hyaluronidase nor collagenase was able to unmask 
tenascin in mature cartilage matrix. In some partially dif- 
ferentiated cartilages, hyaluronldase treatment removed in- 
tracellular staining and unveiled pericellular staining with 
anti-tenascin, but staining was never unmasked in additional 
areas of tissue (not shown). 
Bone Development 
Tenascin appeared with the mesenchymal condensation of 
forming bones which develop by intramembranous ossifica- 
tion. Tenascin was present in the newly condensed frontal 
bone of a  D-d-old rat fetus (Fig. 2, a  and c). 2 d later the 
staining was more intense (Fig. 2, b and d). At this stage 
some bone spicules had been laid down and tenascin was 
present around these. Fig. 2, e and  f, shows a higher magnifi- 
cation of the frontal bone of a D-d-old rat fetus, stained with 
anti-fibronectin and anti-tenascin, respectively. Both fibro- 
nectin and tenascin were present in fibrils aligned in the 
plane of the future bone.  The tenascin-containlng fibrils, 
however,  appeared to be thicker than the fibronectin-con- 
mining fibrils. Fig. 2, g and h, shows sections through the 
membranous portion of the mandible of a D-d-old rat fetus. 
Once  again  tenascin-containing fibrils  were  thicker  than 
fibronectin-containing fibrils, but in this case they were ar- 
ranged without orientation. 
Bones which form by endochondral ossification, including 
long bones, ribs, vertebrae, and some of the cranial bones, 
were examined in sections of whole rat and mouse fetuses. 
Tenascin appeared and disappeared during formation of the 
cartilage model, just as in the development of  cartilage which 
remains as cartilage in the adult (described above). Strong 
staining with anti-tenascin was seen in the early condensa- 
tions of rib and vertebral body anlagen in a 13-d-old rat fetus 
(Fig. 3, a and b). In the vertebral bodies of 17-d-old rat fe- 
tuses the well-differentiated cartilage matrix no longer con- 
tained tenascin, but fibronectin was still detectable (Fig. 3, 
f-h). By this stage the cartilage models of the ribs were being 
replaced by bone spicules (Fig. 3 c). Tenascin was absent 
from the hypertrophic cartilage but present around the invad- 
ing osteogenic cells, around the bone spicules, and in the 
thick band of poorly differentiated presumptive osteoblasts 
surrounding  the  existing bone  and  cartilage  (Fig.  3  d). 
Fibronectin was present throughout the cell layers and par- 
ticularly abundant in the hypertrophic cartilage (Fig. 3 e). 
The sequence of tenascin staining seen in ribs was also 
seen in developing limb long bones. In the femur of a  17- 
d-old mouse fetus tenascin was present in the perichondrium 
and in the matrix surrounding poorly differentiated chondro- 
cytes at the growing ends of the bone. It was also present 
around the osteogenic cells replacing the cartilage model in 
the diaphysis of the bone (Fig. 4, a-c). Tenascin was not de- 
tectable in fully differentiated or hypertrophic cartilage. 
Tenascin was undetectable in fully differentiated bone ma- 
trix. The mandibular bone of a 20-d-old rat, which forms 
by intramembranous ossification, contained tenascin only on 
the periosteal and endosteal surfaces, as well as in bone mar- 
row cavities (Fig. 4, d and e). The fully differentiated osteo- 
cytes embedded in the bone matrix were negative as was the 
mature bone matrix.  Treatment of the sections with hyal- 
uronldase or collagenase did not reveal other antigenic sites. 
Tenascin Promotes Chondrogenesis In Vitro 
When  wing  buds  from 4-d-old  chick  embryos  are  dis- 
sociated and grown in culture at a cell density higher than 
confluency, cell aggregates form and differentiate into car- 
tilage  nodules,  as judged  by  the  presence  of an  Alcian 
blue-staining ECM (1). Tenascin was detectable by immt,  no- 
fluorescent staining in 2-d-old cultures in a patchy distribu- 
tion, whereas fibronectin was present in a rather homoge- 
neous fibrillar distribution (Fig. 5, a and b). By the fourth 
day in culture the cartilage nodules stained intensely with 
anti-tenascin and thick fibrils of tenascin were visible con- 
necting the nodules to each other (Fig. 5 c). Fibronectin was 
not codistributed with tenascin; the thick fibrils seen with 
anti-tenascin could not be seen with anti-fibronectin (Fig. 5, 
d and e). Some individual fibrils which were stained with 
anti-tenascin could even be seen under phase-contrast mi- 
croscopy (Fig.  5, fand g). 
Wing bud cells were cultured on tissue culture plastic 
coated with fibronectin, or tenascin, or without coating, to 
examine the effect of the different substrates on chondrocyte 
differentiation. The addition of fibronectin to the culture 
medium has been shown to inhibit chondrogenesis in such 
cultures (34). A fibronectin-coated substrate also had an in- 
hibitory effect on the development of Alcian blue-stainable 
cartilage nodules and more myotubes were discernable than 
on the other substrates (Fig. 6 b).  A tenascin-coated sub- 
strate had the opposite effect and promoted the formation of 
cartilage nodules (Fig. 6 c).  In seven independent experi- 
ments ~10-fold more cartilage nodules formed on tenascin 
than on fibronectin and about three times as many formed on 
tenascin as on uncoated plastic (Fig. 6, d-f). Hyaluronic acid 
is known to promote in vitro chondrogenesis (22), and tenas- 
cin is known to bind to proteoglycans (8). Therefore, in one 
experiment we  treated  tenascin,  fibronectin,  and  control 
(BSA-treated)  substrates with hyaluronidase to ensure that 
the tenascin effect was not due to any associated hyaluronic 
acid. Hyaluronidase treatment reduced the number of carti- 
lage  nodules  on  all  substrates  tested  (Table  I).  Since 
hyaluronidase reduced nodule formation even on the control 
substrate, it is unlikely that its effect was the result of  removal 
of bound hyaluronate. The effect could perhaps have been 
due to binding of hyaluronldase to the substrates. Hyaluron- 
idase-treated tenascin still had a  significant chondrogenic 
effect (Table I). The effect of tenascin on wing bud cell at- 
tachment was also investigated. The cells were plated on un- 
coated, fibronectin- or tenascin-coated wells in the presence 
or absence of exogenous tenascin. The number of cells at- 
tached was highest on fibronectin and lowest on tenascin. 
The addition of tenascin to the medium reduced cell attach- 
ment on all substrates, including fibronectin, by ~50 % (Ta- 
ble II). Those cells which did attach in the presence of tenas- 
cin were rounded and not as well spread as cells in medium 
without tenascin (not shown). 
Mackie et al. Tenascin in Chondrogenesis  and Osteogenesis  2573 The Journal of Cell Biology, Volume 105,  1987  2574 Figure 4.  Distribution of tenascin in the developing femur and in mature bone. Serial longitudinal cryosections through the femur of a 
D-d-old mouse fetus stained with hematoxylin and eosin (a), or by indirect immunofluorescence with preimmune (b), or anti-tenascin 
serum (c). Cryosections through the ramus of the mandibular bone of a 20-d-old rat stained by the indirect immunoperoxidase method 
with anti-tenascin (d) or normal rabbit serum (e). bin, bone marrow; bs, bone spicules; db, dense bone; dc, differentiated cartilage; en, 
endosteal surface; hc~ hypertrophic cartilage; pe, periosteum. Bar, 200 gm. 
Figure 3. Distribution of tenascin and fibronectin during endocbondral ossification. Serial sagittal cryosections through condensing mesen- 
chyme of ribs and vertebral column of a  13-d-old rat fetus, stained with hematoxylin and eosin (a), or stained by indirect immunofluores- 
cence with anti-tenascin (b). The area shown in a corresponds to the area outlined on the left in b. Serial cryosections through a rib (c-e) 
and the vertebral column (f-h) of a  17-d-old rat fetus, stained with Alcian blue and counterstained with hematoxylin and picro-ponceau 
(c and f), or stained by indirect immunofluorescence with anti-tenascin (d and g) or anti-fibronectin (e and h) serum, bs, Bone spicules; 
hc, hypertrophic cartilage; id, intervertebral disc; po, presumptive osteoblasts; r, rib; vb, vertebral body. Bars, (a and b) 200 I~m; (c-h) 
50 gm. 
Mackie et al. Tenascin  in Chondrogenesis  and Osteogenesis  2575 Figure 5. Distribution of tenascin and fibronectin in wing bud cultures. Indirect immunofluorescence of wing bud cultures stained 2 d (a 
and b), or 4 d (c-f) after plating with anti-fibronectin (a and d) or anti-tenascin (b, c, e, and  f); d and e show the same feld double-stained 
with anti-fibronectin and anti-tenascin sera. The arrows in f indicate fibrils, stained by anti-tenascin,  that can be seen in the same field 
viewed by phase contrast (g). Bar, 50 ~m. 
Discussion 
In this study tenascin was found to be associated with chon- 
drogenic and osteogenic tissues undergoing differentiation. 
It was present in the early mesenchymal condensations of 
cartilage and bone anlagen but not in the surrounding mesen- 
chyme. It progressively disappeared with the accumulation 
of mature cartilage or bone matrix. Tenascin was retained, 
however, in the perichondrium, which provides a source of 
cells to differentiate into chondroblasts. The immunofluores- 
cent staining of tenascin in perichondrium was much more 
intense in the growing fetal cartilages than in adult cartilage 
which has the potential for regeneration but is not growing. 
The analogous situation is seen with tenascin during tooth 
development. Tenascin is expressed by dental papilla cells 
early in development but once these cells differentiate into 
the dentin-producing odontoblasts tenascin is no longer ex- 
pressed. Tenascin continues to be abundant in the tooth pulp 
which has the capacity for hard tissue formation (Thesleff, 
I.,  E.  J.  Mackie,  S.  Vainio,  and  R.  Chiquet-Ehrismann, 
manuscript submitted for publication). Tenascin is not exclu- 
sively present in developing hard tissues. It is found in the 
dense mesenchyme surrounding the budding epithelial rudi- 
ments of mammary gland, hair follicle, and molar tooth (10). 
The Journal of Cell Biology, Volume  105, 1987  2576 Table II.  Inhibition  of Cell Attachment  by  Tenascin 
Cell attachment* 
20 I~g/ml Tenascin addition 
Substrate  No addition  to medium 
%  % 
No coating  59  28 
Fibronectin  100  43 
Tenascin  48  18 
* Results are expressed as percentage of cells attached/field on a fibronectin- 
coated substrate without tenascin in the medium, where 363 cells were counted 
in three fields. For all other combinations of experimental conditions the cells 
in at least five fields were counted. 
Figure 6.  Tenascin promotes the formation of cartilage nodules. 
Wing bud cultures grown on uncoated (a and d), fibronectin-coated 
(b and e), or tenascin-coated  (c and f) wells, viewed under phase- 
contrast microscopy (a-c) or bright field (d-f) for visualization of 
Alcian blue-stained nodules. Bar, 200 ~tm. 
It is also present in myotendinous junctions, tendons, and 
smooth muscle (7). In all these situations, however, the sur- 
rounding mesenchyme contains no tenascin. 
Tenascin, because of  its distribution during hard tissue for- 
marion,  is  unique among the ECM molecules so far de- 
scribed. Collagen type I, which is absent from mature carti- 
lage matrix, is present throughout the limb-bud mesenchyme 
and becomes more concentrated in cartilage anlagen with 
mesenchymai cell condensation (11). Tenascin, on the other 
Table I.  Cartilage Nodule Formation on Different 
Substrates 
No. of cartilage 
Coating  Hyaluronidase  nodules/well  n 
Control (BSA)  +  1.8 +  1.5  6 
-  2.5  5:1.4  6 
Fibronectin  +  0 5: 0*  6 
-  0.5  5:  0.5w  6 
Tenascin  +  5.8 5: 2.3w  9 
-  7.3  5:  2.6w  9 
* Mean  +  SD of n wells. 
r Significantly different from appropriate control value (P <  0.01). 
w  Significantly different from appropriate control value (P <  0.005). 
hand, was found to be absent from the mesenchyme sur- 
rounding  cartilage  and  bone  anlagen.  A  recent  report 
demonstrates that peanut agglutinin binds specifically to an 
extracellular component of precartilage cellular aggregates 
both in vivo and in vitro (2). This component appears to have 
a  similar  distribution  to  tenascin  and  may,  indeed,  be 
tenascin. 
Fibronectin, like collagen type I, is ubiquitous in mesen- 
chymal tissues and increases in concentration in cartilage an- 
lagen with mesenchymal  cell condensation (11). In one study, 
fibronectin was found to be absent from mature cartilage ma- 
trix (11) whereas others have shown that its presence can be 
unmasked or enhanced by hyaluronidase treatment of sec- 
tions (14, 37). Our results confirm that, at least in the car- 
tilages we examined, fibronectin is present and its staining 
can be enhanced by hyaluronidase treatment. 
Vaughan et al. (35) have recently suggested that tenascin 
could serve as a structural component of differentiated carti- 
lage since substantial quantifies could be extracted from fetal 
chick sterna. The results of the present study indicate, how- 
ever,  that tenascin is absent from fully differentiated car- 
tilage matrix and, therefore, is not a structural component of 
mature cartilage. To confirm this, we examined by immuno- 
histochemistry  the presence of  tenascin in sterna from chicks 
of the same stage as those used by Vanghan et al. In sections 
treated  with hyaluronidase, tenascin  staining was  present 
around the relatively undifferentiated cells at the growing 
edges of the cartilage but absent from the matrix produced 
by  the  central,  differentiated  chondrocytes  (results  not 
shown). 
The results of the immunohistochemical studies presented 
here demonstrate that tenascin is associated with determined 
but not fully  differentiated, growing areas of  developing bone 
and cartilage. In vitro studies were devised to investigate the 
function of tenascin during chondrogenesis. 
Wing bud cells grown in culture produced tenascin mainly 
in the cartilage-forming nodules, whereas fibronectin was 
present throughout the cultures.  Zanetti and Solursh (40) 
have also described staining of the matrix of cartilage colo- 
nies by M1, a monoclonal antibody to tenascin. In the present 
study,  thick,  tenascin-stained  fibrils  developed,  intercon- 
necting the cartilage nodules. The staining pattern of such 
cultures with anti-tenascin was reminiscent of the patterns 
of tension created by fibroblasts or tissue explants in collagen 
gels described by Harris et al. (16) and Stopak and Harris 
(33).  It  is  tempting  to  speculate  that  tension  in  nodule- 
forming wing bud  cultures  induces the deposition of the 
Mackie et al.  Tenascin  in Chondrogenesis and Osteogenesis  2577 tenascin-stained fibrils in an organized pattern. If this is so, 
tenascin could participate in translating patterns of mechani- 
cal force into a specific protein structure. Such a structure 
could then serve as a building block for the formation of  hard 
tissue or tendon. 
Tenascin as a  substrate promoted chondrogenesis by as 
much as fibronectin inhibited it. The inhibition of chrondo- 
genesis by fibronectin is in agreement with previously pub- 
lished work (27, 34, 38). There are several possible explana- 
tions for the chondrogenesis-promoting effect of tenascin. 
Tenascin may selectively allow the attachment or growth of 
cells which have already been determined as chondroblasts, 
or tenascin may actively influence the outcome of  determina- 
tion of wing bud cells. Cultures grown on a fibronectin sub- 
strate contained more myogenic cells than on the other sub- 
strates examined. The effect on myoblasts is likely to be due 
to selective attachment, since they are known to be particu- 
larly dependent on exogenous fibronectin for attachment (9). 
The myoblasts are not derived from the limb bud mesen- 
chyme but rather have immigrated from the somite and are 
already determined at the time of culture (6). The fibroblast 
and chondroblast phenotypes, on the other hand, are proba- 
bly not yet determined at the time of culture,  since it is 
known that the transition of  ehondroblasts into fibroblast-like 
cells in the nresence offibronectin is reversible (38). It seems 
likely, therefore, that the increase in the number of chondro- 
genie nodules on tenascin substrates is due to the promotion 
of chondroblast differentiation and not due to selection. 
The chondroblast phenotype is dependent on cell shape (3, 
32). When wing bud cells are grown under conditions which 
allow  them  to  become  rounded  they  start  to  produce 
cartilage-specific  matrix  components.  In  addition,  when 
wing  bud  cells  are  treated  with  agents  that disrupt  the 
cytoskeleton the cells become rounded and undergo chon- 
drogenic differentiation (39). In the present study, tenascin 
was able to antagonize the attachment of wing bud cells to 
fibronectin, and the cells that attached in the presence of 
tenascin were rounded. Thus it is possible that tenascin inter- 
feres with the communication between fibronectin and the 
cytoskeleton, causing cell rounding and chondrogenic dif- 
ferentiation. The fact that tenascin was able to modulate the 
interaction of  wing bud cells with fibronectin may explain the 
apparently contradictory information  that fibronectin is pres- 
ent in vivo throughout chondrogenesis but inhibits this pro- 
cess in vitro. Perhaps one role of tenascin, which is present 
in chondrogenic areas but not in the surrounding mesen- 
chyme, is to override the anti-chondrogenic effect of fibro- 
nectin. 
We have previously found that tenascin is present in the 
condensed mesenchyme of fetal mammary gland, hair folli- 
cle, and molar tooth (10). Since mesenchymal condensation 
is an essential preliminary step in cartilage formation, and 
because of the remarkable association of tenascin with con- 
densing mesenchyma, the possibility that tenascin  is  in- 
volved in this process must be considered. Tenascin has been 
found to cause the aggregation of erythroeytes (10). In the in 
vitro studies presented here it was not possible to observe an 
effect  of exogenous tenascin on aggregation of wing bud cells 
since  the  cells  aggregated  spontaneously.  The  results  of 
previous studies suggest that precartilage mesenchymal con- 
densation is not a result of increased mitosis but of the move- 
ment of cells toward each other (12). Oster et al. (25) have 
suggested that the production of hyaluronidase and resultant 
breakdown  of extraceUular  hyaluronate brings  the  cells 
closer together and is theoretically sufficient to cause carti- 
lage  condensation.  Singley  and  Solursh  (31), however, 
demonstrated that there is no decrease in hyaluronate in con- 
densing cartilage anlagen. These authors suggested that the 
retraction of cell processes with cell rounding that they ob- 
served in their EM studies results in condensation. Tenascin 
may contribute to the condensation process through a mecha- 
nism analogous to that involved in cell aggregation in vitro, 
as well as by causing cell rounding. 
In conclusion, tenascin was found to be present in a strik- 
ingly restricted distribution in chondrogenic and osteogenic 
tissues, and to promote chondrogenesis in vitro. We suggest 
that tenascin plays an important role in the differentiation of 
hard tissue forming cells, possibly by allowing cells to detach 
from  the  fibronectin-containing  ECM  and  causing  cell 
rounding and condensation. 
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